These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29778772)

  • 1. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.
    Meyerson BE; Agley JD; Davis A; Jayawardene W; Hoss A; Shannon DJ; Ryder PT; Ritchie K; Gassman R
    Drug Alcohol Depend; 2018 Jul; 188():187-192. PubMed ID: 29778772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order.
    Eldridge LA; Agley J; Meyerson BE
    J Am Pharm Assoc (2003); 2020; 60(3):470-474. PubMed ID: 31917248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with naloxone availability and dispensing through Michigan's pharmacy standing order.
    Dahlem CH; Myers M; Goldstick J; Stevenson JG; Gray G; Rockhill S; Dora-Laskey A; Kellenberg J; Brummett CM; Kocher KE
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):454-463. PubMed ID: 35405078
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies.
    Contreras J; Baus C; Brandt C; Witry M; Peters J; Evoy KE
    J Am Pharm Assoc (2003); 2021; 61(2):e94-e99. PubMed ID: 33153912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.
    Graves RL; Andreyeva E; Perrone J; Shofer FS; Merchant RM; Meisel ZF
    J Addict Med; 2019; 13(4):272-278. PubMed ID: 30585876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program.
    Hanson KA; Smart MH; Mandava MR; Carkovic E; Aslamy M; Lee TA; Pickard AS
    J Am Pharm Assoc (2003); 2023; 63(2):608-613.e3. PubMed ID: 36631342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.
    Pollini RA; Slocum S; Ozga J; Joyce R; Xuan Z; Green TC; Walley AY
    J Am Pharm Assoc (2003); 2022; 62(1):157-166. PubMed ID: 34511372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia.
    Karthikeyan N; Xia T; Nielsen S; Picco L
    Drug Alcohol Rev; 2024 Jul; 43(5):1305-1312. PubMed ID: 38691509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions.
    Meyerson BE; Davis A; Agley JD; Shannon DJ; Lawrence CA; Ryder PT; Ritchie K; Gassman R
    Int J Drug Policy; 2018 Jun; 56():46-53. PubMed ID: 29558701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
    Thornton JD; Lyvers E; Scott VGG; Dwibedi N
    J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists in Virginia dispensing naloxone under a standing order: A qualitative study.
    Ijioma SC; Fernández EV; Gatewood SB; Carroll NV; Salgado TM
    J Am Pharm Assoc (2003); 2021; 61(6):753-760.e1. PubMed ID: 34229945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access.
    Egan KL; Foster SE; Knudsen AN; Lee JGL
    Am J Prev Med; 2020 May; 58(5):699-702. PubMed ID: 32005590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of Naloxone in Pharmacies and Knowledge of Pharmacy Staff Regarding Dispensing Naloxone to Younger Adolescents.
    Jimenez DE; Singer MR; Adesman A
    J Adolesc Health; 2019 Nov; 65(5):698-701. PubMed ID: 31540779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.
    Pollini RA; Slocum S; Ozga JE; Joyce R; Xuan Z; Green TC; Walley AY
    J Am Pharm Assoc (2003); 2022; 62(5):1546-1554. PubMed ID: 35450833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy Naloxone Standing Order and Community Opioid Fatality Rates Over Time.
    Xuan Z; Walley AY; Yan S; Chatterjee A; Green TG; Pollini RA
    JAMA Netw Open; 2024 Aug; 7(8):e2427236. PubMed ID: 39207758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to naloxone at community pharmacies under the Massachusetts statewide standing order.
    Wu C; Brown T; Moreno JL
    J Am Pharm Assoc (2003); 2020; 60(4):647-652. PubMed ID: 31843374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.